1. Cruz, Sam Ezrael Dela, Bagamasbad, Pia. 2022. The Effect of Glucocorticoids on TAF1 Gene Transcription in X-linked Dystonia Parkinsonism. In Journal of the ASEAN Federation of Endocrine Societies, 38, 23-30. doi:10.15605/jafes.037.S6. https://pubmed.ncbi.nlm.nih.gov/37234925/
2. Janakiraman, Udaiyappan, Yu, Jie, Moutal, Aubin, Khanna, Rajesh, Nelson, Mark A. 2019. TAF1-gene editing alters the morphology and function of the cerebellum and cerebral cortex. In Neurobiology of disease, 132, 104539. doi:10.1016/j.nbd.2019.104539. https://pubmed.ncbi.nlm.nih.gov/31344492/
3. Crombie, Elisa M, Cleverley, Karen, Timmers, H T Marc, Fisher, Elizabeth M C. 2024. The roles of TAF1 in neuroscience and beyond. In Royal Society open science, 11, 240790. doi:10.1098/rsos.240790. https://pubmed.ncbi.nlm.nih.gov/39323550/
4. Petrozziello, Tiziana, Dios, Amanda M, Mueller, Kaly A, Bragg, D Cristopher, Sadri-Vakili, Ghazaleh. 2020. SVA insertion in X-linked Dystonia Parkinsonism alters histone H3 acetylation associated with TAF1 gene. In PloS one, 15, e0243655. doi:10.1371/journal.pone.0243655. https://pubmed.ncbi.nlm.nih.gov/33315879/
5. Zhang, Jing, Li, Rong, Zhang, Boxiang, Cui, Xiaohai. 2022. TAF1 promotes NSCLC cell epithelial-mesenchymal transition by transcriptionally activating TGFβ1. In Biochemical and biophysical research communications, 636, 113-118. doi:10.1016/j.bbrc.2022.10.099. https://pubmed.ncbi.nlm.nih.gov/36368153/
6. Cheng, Hanyin, Capponi, Simona, Wakeling, Emma, Timmers, H T Marc, Lyon, Gholson J. 2019. Missense variants in TAF1 and developmental phenotypes: challenges of determining pathogenicity. In Human mutation, , . doi:10.1002/humu.23936. https://pubmed.ncbi.nlm.nih.gov/31646703/